Logo image of MRNA

MODERNA INC (MRNA) Stock Analyst Ratings

NASDAQ:MRNA - Nasdaq - US60770K1079 - Common Stock - Currency: USD

35.53  +1.8 (+5.34%)

After market: 35.53 0 (0%)

Buy % Consensus

65

ChartMill assigns a Buy % Consensus number of 65% to MRNA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 63.88. This target is 79.78% above the current price.
MRNA was analyzed by 32 analysts. The buy percentage consensus is at 65. So analysts seem to be rather neutral about MRNA.
In the previous month the buy percentage consensus was at a similar level.
MRNA was analyzed by 32 analysts, which is quite many. So the average rating should be quite meaningful.
MRNA Historical Analyst RatingsMRNA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -72 -65 -58 -51 -44 -37 -30 -23 -16 -9 -2 10 20 30

Price Target & Forecast

Price Low Median Mean High 35.5325.2549.9863.88222.60 - -28.93% 40.67% 79.78% 526.51%
MRNA Current Analyst RatingMRNA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15
Up and Down Grades
Date Firm Action Rating
2025-02-19 UBS Maintains Buy -> Buy
2025-02-18 RBC Capital Reiterate Sector Perform -> Sector Perform
2025-02-18 Barclays Downgrade Overweight -> Equal-Weight
2025-02-11 B of A Securities Maintains Underperform -> Underperform
2025-01-29 Goldman Sachs Downgrade Buy -> Neutral
2025-01-28 Goldman Sachs Maintains Buy -> Buy
2025-01-27 Evercore ISI Group Maintains In-Line -> In-Line
2025-01-15 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2025-01-08 UBS Maintains Buy -> Buy
2024-12-18 Argus Research Downgrade Buy -> Hold
2024-12-10 B of A Securities Reiterate Underperform
2024-11-26 JP Morgan Maintains Underweight -> Underweight
2024-11-18 Piper Sandler Reiterate Overweight -> Overweight
2024-11-18 HSBC Upgrade Hold -> Buy
2024-11-15 Wolfe Research Initiate Underperform
2024-11-08 Needham Reiterate Hold
2024-11-08 Barclays Maintains Overweight -> Overweight
2024-11-04 JP Morgan Maintains Underweight -> Underweight
2024-10-24 UBS Maintains Buy -> Buy
2024-10-17 Bernstein Initiate Market Perform
2024-10-15 Jefferies Maintains Hold -> Hold
2024-09-19 RBC Capital Reiterate Sector Perform -> Sector Perform
2024-09-16 Barclays Maintains Overweight -> Overweight
2024-09-16 Goldman Sachs Maintains Buy -> Buy
2024-09-13 TD Cowen Maintains Hold -> Hold
2024-09-13 Needham Reiterate Hold
2024-09-13 Oppenheimer Downgrade Outperform -> Perform
2024-09-13 RBC Capital Maintains Sector Perform -> Sector Perform
2024-09-13 JP Morgan Downgrade Neutral -> Underweight
2024-09-13 B of A Securities Maintains Neutral -> Neutral